Modi-1 — Investigational Agent
Other · Phase 1/2 · Scancell
Mechanism of Action
A therapeutic cancer vaccine (Moditope platform) presenting citrullinated tumor peptides to stimulate CD4 cytotoxic T-cell responses against stress-induced post-translationally modified antigens on tumor cells.
Investigational Indications
- Triple-negative breast cancer
- Head and neck cancer
- Ovarian cancer
- Renal cancer